BRAF mutation is not predictive of long-term outcome in papillary thyroid carcinoma

Authors

Lauren E. Henke, Washington University School of Medicine in St. Louis
John D. Pfeifer, Washington University School of Medicine in St. Louis
Changquing Ma, Washington University School of Medicine in St. Louis
Stephanie M. Perkins, Washington University School of Medicine in St. Louis
Todd DeWees, Washington University School of Medicine in St. Louis
Samir El-Mofty, Washington University School of Medicine in St. Louis
Jeffrey F. Moley, Washington University School of Medicine in St. Louis
Brian Nussenbaum, Washington University School of Medicine in St. Louis
Bruce H. Haughey, Washington University School of Medicine in St. Louis
Thomas J. Baranski, Washington University School of Medicine in St. Louis
Julie K. Schwarz, Washington University School of Medicine in St. Louis
Perry W. Grigsby, Washington University School of Medicine in St. LouisFollow

Journal

Cancer medicine

Publication Date

2015

Volume

4

Issue

6

Inclusive Pages

791-799

Document Type

Open Access Publication

Rights and Permissions

Cancer Medicine 2015, 4(6):791–799 Copyright 2015 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Henke, Lauren E.; Pfeifer, John D.; Ma, Changquing; Perkins, Stephanie M.; DeWees, Todd; El-Mofty, Samir; Moley, Jeffrey F.; Nussenbaum, Brian; Haughey, Bruce H.; Baranski, Thomas J.; Schwarz, Julie K.; and Grigsby, Perry W., "BRAF mutation is not predictive of long-term outcome in papillary thyroid carcinoma." Cancer medicine. 4, 6. 791-799. (2015).
https://digitalcommons.wustl.edu/open_access_pubs/3900